“…35 In limited case series/reports, SCIG was well tolerated and efficacious at increasing IgG levels or preventing infections in 10 LT recipients and 1 HT recipient with SHG. 44,45 Insurance has been cited as a barrier to initiating IgG-RT in LT patients with SHG, 291 and it must be noted that both IVIG and SCIG are currently not FDA-approved for post-SOT SHG.…”